Infection of cells with varicella-zoster virus down-regulates surface expression of class I major histocompatibility complex antigens

Journal of Infectious Diseases

Volumn 177, Issue 5, 1998, Pages 1390-1393

  Cohen, Jeffrey I ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FIBROBLAST; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; PRIORITY JOURNAL; PROTEIN PROCESSING; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

EID: 0031948857     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517821     Document Type: Article

References (16)

1. Wold WSM, Gooding LR. Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 1991;184:1-8.
2. Mellencamp, MW, O'Brien PCM, Stevenson JR. Pseudorabies virus-induced suppression of major histocompatibility complex class I antigen expression. J Virol 1991;65:3365-8.
3. Ahn K, Gruhler A, Galocha B, et al. The ER-Iuminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 1997;6:613-21.
4. Hill A, Jugovic P, York I, et al. Herpes simplex virus turns off the TAP to evade host immunity. Nature 1995;375:411-5.
5. Ameborn P, Biberfeld G. T-lymphocyte subpopulations in relation to immunosuppression in measles and varicella. Infect Immun 1983; 39:29-37.
6. Arvin AM, Koropchak CM, Williams BRG, Grumet FC, Foung SK. Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J Infect Dis 1986; 154:422-9.
7. Arvin, AM. Cell-mediated immunity to varicella-zoster virus. J Infect Dis 1992;166(suppl 1):S35-41.
8. Diaz PD, Smith S, Hunter E, Arvin AM. T-lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine. J Immunol 1989; 142:636-41.
9. Hayward AR, Pontesilli O, Herberger M, Laszlo M, Levin M. Specific lysis of varicella-zoster virus-infected B lymphoblasts by human T-cells. J Virol 1986;58:179-84.
10. Hickling JK, Borysiewicz LK, Sissons JGP. Varicella-zoster virus-specific cytotoxic T lymphocytes (Tc): detection and frequency analysis of HLA class I-restricted Tc in human peripheral blood. J Virol 1987;61: 3463-9.
11. + phenotype. J Immunol 1991:146:257-64.
12. Parham P, Barnstable CJ, Bodmer WF. Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C antigens. J Immunol 1979; 123:342-9.
13. 2-microglobulin gene expression. J Clin Invest 1991; 87: 284-92.
14. Cohen JI, Seidel KE. Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro. Proc Natl Acad Sci USA 1993; 90:7376-80.
15. Cohen, JI, Straus SE, Varicella-zoster virus and its replication, In: Fields BN, Knipe DN, Howley PM, et al., eds. Fields virology, Philadelphia: Lippincott-Raven Publishers, 1996:2525-45.
16. Kennedy PGE, Major EO, Williams RK, Straus SE Down-regulation of glial fibrillary acidic protein expression during acute lytic varicellazoster virus infection of cultured human astrocytes. Virology 1994; 205: 558-62.